Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Sexton

Showing results (331-340 of 518) with videos related to

Pageof 52
Sort By:
Nature Communications|February 9, 2018
Correspondence: Reply to 'Compound 17b and formyl peptide receptor biased agonism in relation to cardioprotective effects in ischaemia-reperfusion injury'Cheng Xue Qin, Lauren T May, Patrick M Sexton, et al.
Molecular Pharmacology|May 26, 2007
Structure-function studies of allosteric agonism at M2 muscarinic acetylcholine receptorsLauren T May, Vimesh A Avlani, Christopher J Langmead, et al.
ACS Chemical Neuroscience|April 24, 2018
Structure-Activity Relationships of Pan-Gα<sub>q/11</sub> Coupled Muscarinic Acetylcholine Receptor Positive Allosteric ModulatorsAlice E Berizzi, Aaron M Bender, Craig W Lindsley, et al.
Urologic Oncology|January 16, 2021
Do patients with a PI-RADS 5 lesion identified on magnetic resonance imaging require systematic biopsy in addition to targeted biopsy?Justin N Drobish, Mark D Bevill, Chad R Tracy, et al.
The Journal of Biological Chemistry|April 23, 2014
Allosteric modulation of M1 muscarinic acetylcholine receptor internalization and subcellular traffickingHolly R Yeatman, J Robert Lane, Kwok Ho Christopher Choy, et al.
Australasian Radiology|July 20, 2005
Importance of radiation time and dose factors on outcome for childhood medulloblastomaM Back, V Ahern, M Berry, et al.
The Journal of Biological Chemistry|July 10, 2014
Molecular mechanisms of bitopic ligand engagement with the M1 muscarinic acetylcholine receptorPeter Keov, Laura López, Shane M Devine, et al.
Biochemical Pharmacology|July 20, 2020
Evaluation of biased agonism mediated by dual agonists of the GLP-1 and glucagon receptorsSanaz Darbalaei, Elita Yuliantie, Antao Dai, et al.
Molecular Pharmacology|October 3, 2025
Cholesterol residence time drives regulation of the G protein-coupled cholecystokinin receptorChirine Toufaily, Yuanyuan Ma, Emmanuel D Barbosa, et al.
Biochemical Pharmacology|August 15, 2024
Isoquinoline small molecule ligands are agonists and probe-dependent allosteric modulators of the glucagon subfamily of GPCRsElita Yuliantie, Phuc Nh Trinh, Caroline Hick, et al.
Pageof 52

Showing results (331-340 of 518) with videos related to

Sort By:
Pageof 52
Nature Communications|February 9, 2018
Correspondence: Reply to 'Compound 17b and formyl peptide receptor biased agonism in relation to cardioprotective effects in ischaemia-reperfusion injury'Cheng Xue Qin, Lauren T May, Patrick M Sexton, et al.
Molecular Pharmacology|May 26, 2007
Structure-function studies of allosteric agonism at M2 muscarinic acetylcholine receptorsLauren T May, Vimesh A Avlani, Christopher J Langmead, et al.
ACS Chemical Neuroscience|April 24, 2018
Structure-Activity Relationships of Pan-Gα<sub>q/11</sub> Coupled Muscarinic Acetylcholine Receptor Positive Allosteric ModulatorsAlice E Berizzi, Aaron M Bender, Craig W Lindsley, et al.
Urologic Oncology|January 16, 2021
Do patients with a PI-RADS 5 lesion identified on magnetic resonance imaging require systematic biopsy in addition to targeted biopsy?Justin N Drobish, Mark D Bevill, Chad R Tracy, et al.
The Journal of Biological Chemistry|April 23, 2014
Allosteric modulation of M1 muscarinic acetylcholine receptor internalization and subcellular traffickingHolly R Yeatman, J Robert Lane, Kwok Ho Christopher Choy, et al.
Australasian Radiology|July 20, 2005
Importance of radiation time and dose factors on outcome for childhood medulloblastomaM Back, V Ahern, M Berry, et al.
The Journal of Biological Chemistry|July 10, 2014
Molecular mechanisms of bitopic ligand engagement with the M1 muscarinic acetylcholine receptorPeter Keov, Laura López, Shane M Devine, et al.
Biochemical Pharmacology|July 20, 2020
Evaluation of biased agonism mediated by dual agonists of the GLP-1 and glucagon receptorsSanaz Darbalaei, Elita Yuliantie, Antao Dai, et al.
Molecular Pharmacology|October 3, 2025
Cholesterol residence time drives regulation of the G protein-coupled cholecystokinin receptorChirine Toufaily, Yuanyuan Ma, Emmanuel D Barbosa, et al.
Biochemical Pharmacology|August 15, 2024
Isoquinoline small molecule ligands are agonists and probe-dependent allosteric modulators of the glucagon subfamily of GPCRsElita Yuliantie, Phuc Nh Trinh, Caroline Hick, et al.
Pageof 52